Geode Capital Management
OCUL icon

Geode Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$30.5M Sell
3,284,171
-138,241
-4% -$1.28M ﹤0.01% 1721
2025
Q1
$25.1M Buy
3,422,412
+186,100
+6% +$1.36M ﹤0.01% 1781
2024
Q4
$27.6M Sell
3,236,312
-34,895
-1% -$298K ﹤0.01% 1785
2024
Q3
$28.5M Sell
3,271,207
-180,880
-5% -$1.57M ﹤0.01% 1794
2024
Q2
$23.6M Buy
3,452,087
+966,044
+39% +$6.61M ﹤0.01% 1843
2024
Q1
$22.6M Buy
2,486,043
+749,229
+43% +$6.82M ﹤0.01% 1856
2023
Q4
$7.75M Buy
1,736,814
+107,286
+7% +$479K ﹤0.01% 2472
2023
Q3
$5.12M Buy
1,629,528
+59,624
+4% +$187K ﹤0.01% 2627
2023
Q2
$8.1M Buy
1,569,904
+112,164
+8% +$579K ﹤0.01% 2416
2023
Q1
$7.68M Buy
1,457,740
+47,087
+3% +$248K ﹤0.01% 2413
2022
Q4
$3.96M Buy
1,410,653
+39,900
+3% +$112K ﹤0.01% 2777
2022
Q3
$5.69M Buy
1,370,753
+19,328
+1% +$80.2K ﹤0.01% 2602
2022
Q2
$5.43M Sell
1,351,425
-12,545
-0.9% -$50.4K ﹤0.01% 2660
2022
Q1
$6.75M Buy
1,363,970
+46,631
+4% +$231K ﹤0.01% 2615
2021
Q4
$9.18M Buy
1,317,339
+5,104
+0.4% +$35.6K ﹤0.01% 2501
2021
Q3
$13.1M Buy
1,312,235
+7,436
+0.6% +$74.4K ﹤0.01% 2262
2021
Q2
$18.5M Buy
1,304,799
+75,191
+6% +$1.07M ﹤0.01% 2020
2021
Q1
$20.2M Buy
1,229,608
+139,257
+13% +$2.29M ﹤0.01% 1873
2020
Q4
$22.6M Buy
1,090,351
+204,445
+23% +$4.23M ﹤0.01% 1646
2020
Q3
$6.74M Buy
885,906
+72,648
+9% +$553K ﹤0.01% 2218
2020
Q2
$6.77M Buy
813,258
+156,607
+24% +$1.3M ﹤0.01% 2163
2020
Q1
$3.25M Buy
656,651
+85,232
+15% +$422K ﹤0.01% 2403
2019
Q4
$2.26M Buy
571,419
+42,471
+8% +$168K ﹤0.01% 2935
2019
Q3
$1.61M Buy
528,948
+73,663
+16% +$224K ﹤0.01% 3051
2019
Q2
$2M Buy
455,285
+48,725
+12% +$214K ﹤0.01% 2953
2019
Q1
$1.61M Buy
406,560
+55,887
+16% +$222K ﹤0.01% 2976
2018
Q4
$1.4M Buy
350,673
+46,281
+15% +$184K ﹤0.01% 2959
2018
Q3
$2.09M Buy
304,392
+15,198
+5% +$105K ﹤0.01% 2852
2018
Q2
$1.95M Buy
289,194
+54,649
+23% +$369K ﹤0.01% 2873
2018
Q1
$1.53M Buy
234,545
+58,535
+33% +$381K ﹤0.01% 2913
2017
Q4
$783K Sell
176,010
-11,888
-6% -$52.9K ﹤0.01% 3193
2017
Q3
$1.16M Buy
187,898
+6,013
+3% +$37.2K ﹤0.01% 3058
2017
Q2
$1.69M Buy
181,885
+6,524
+4% +$60.5K ﹤0.01% 2830
2017
Q1
$1.63M Buy
175,361
+36,629
+26% +$340K ﹤0.01% 2772
2016
Q4
$1.16M Buy
138,732
+2,663
+2% +$22.3K ﹤0.01% 2919
2016
Q3
$934K Buy
136,069
+59,857
+79% +$411K ﹤0.01% 2971
2016
Q2
$377K Buy
76,212
+5,816
+8% +$28.8K ﹤0.01% 3336
2016
Q1
$680 Buy
70,396
+1,042
+2% +$10 ﹤0.01% 3078
2015
Q4
$649K Buy
69,354
+1,034
+2% +$9.68K ﹤0.01% 3140
2015
Q3
$960K Buy
68,320
+4,269
+7% +$60K ﹤0.01% 2895
2015
Q2
$1.35M Buy
64,051
+28,844
+82% +$606K ﹤0.01% 2744
2015
Q1
$1.48M Buy
35,207
+6,743
+24% +$283K ﹤0.01% 2634
2014
Q4
$669K Buy
28,464
+13,158
+86% +$309K ﹤0.01% 3048
2014
Q3
$229K Buy
+15,306
New +$229K ﹤0.01% 3522